We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Inogen
INGN
$174M
| $261K | ﹤0.01% |
20,915
+4,550
| +28% | +$87.1K |
|
1727
Autohome
ATHM
$2.65B
| $259K | ﹤0.01% |
7,750
+1,800
| +30% | +$60.7K |
|
1728
Consensus Cloud Solutions
CCSI
$683M
| $254K | ﹤0.01% |
7,449
+350
| +5% | +$16.8K |
|
|
SRDX
1729
DELISTED
Surmodics
SRDX
| $251K | ﹤0.01% |
11,020
+2,650
| +32% | +$68.2K |
|
1730
MoonLake Immunotherapeutics
MLTX
$1.59B
| $248K | ﹤0.01% |
+11,575
| New | +$195K |
|
|
NFBK
1731
DELISTED
Northfield Bancorp
NFBK
| $247K | ﹤0.01% |
21,000
+6,650
| +46% | +$95.1K |
|
1732
Scholar Rock
SRRK
$5.92B
| $247K | ﹤0.01% |
30,840
+6,400
| +26% | +$64.9K |
|
1733
HEICO Corp
HEI
$50.8B
| $239K | ﹤0.01% |
1,400
| – | – |
|
|
TVRD
1734
Tvardi Therapeutics
TVRD
$22.9M
| $234K | ﹤0.01% |
1,323
+156
| +13% | +$52.2K |
|
1735
Atea Pharmaceuticals
AVIR
$361M
| $229K | ﹤0.01% |
68,480
+19,500
| +40% | +$79.1K |
|
|
OSG
1736
Octave Specialty Group
OSG
$261M
| $228K | ﹤0.01% |
14,700
| – | – |
|
1737
DXP Enterprises
DXPE
$2.49B
| $217K | ﹤0.01% |
8,050
+2,000
| +33% | +$57.6K |
|
1738
Qfin Holdings
QFIN
$1.66B
| $215K | ﹤0.01% |
11,100
+3,450
| +45% | +$72.3K |
|
1739
Ranpak Holdings
PACK
$550M
| $215K | ﹤0.01% |
41,230
+1,750
| +4% | +$11.1K |
|
1740
Seer Inc
SEER
$118M
| $205K | ﹤0.01% |
53,090
+16,700
| +46% | +$76.8K |
|
1741
Bristow Group
VTOL
$1.34B
| $198K | ﹤0.01% |
8,826
| – | – |
|
1742
Gossamer Bio
GOSS
$100M
| $183K | ﹤0.01% |
145,076
| – | – |
|
1743
Great Southern Bancorp
GSBC
$879M
| $182K | ﹤0.01% |
3,600
+900
| +33% | +$51K |
|
|
CNSL
1744
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $165K | ﹤0.01% |
63,850
+19,250
| +43% | +$69.1K |
|
1745
Weibo
WB
$1.95B
| $164K | ﹤0.01% |
8,200
+1,400
| +21% | +$28.6K |
|
1746
Cardlytics
CDLX
$22.3M
| $162K | ﹤0.01% |
4,782
| – | – |
|
1747
Lufax Holding
LU
$1.33B
| $156K | ﹤0.01% |
19,075
+6,012
| +46% | +$57.6K |
|
1748
Erasca
ERAS
$6.3B
| $151K | ﹤0.01% |
50,000
| – | – |
|
|
JOYY
1749
JOYY Inc
JOYY
$3.77B
| $143K | ﹤0.01% |
4,600
+1,150
| +33% | +$38.7K |
|
1750
Vera Therapeutics
VERA
$2.39B
| $138K | ﹤0.01% |
17,816
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.